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INTRODUCTION
In 2000, Woodbury et al. were the first to induce 
bone marrow stromal cells (BMSCs) to differenti-
ate into the neuronal phenotype in vitro, expressing 
neuron-specific  enolase,  NeuN,  neurofilament-M, 
tau, trKA, and Nestin (Woodbury et al., 2000). Since 
then, the possibility of obtaining neural cells from 
BMSCs, as a new biological concept with potential 
clinical  application,  has  been  extensively  investi-
gated  (Chopp  et  al.,  2002;  Hermann  et  al.,  2004; 
Mahmood  et  al.,  2004;  Zurita  et  al.,  2004,  2006; 
Bossolasco et al., 2005). Bone marrow stromal cells 
would be an ideal source for nerve tissue engineer-
ing if the procedures to harvest them were not so 
painful  and  invasive,  and  if  the  procedures  could 
yield enough BMSCs more easily (Zuk et al., 2001).
Adipose-derived stem cells (ADSCs) are isolated 
from adipose tissue, which is derived from embry-
onic  mesoderm.  These  ADSCs  are  self-renewable 
and  can  differentiate  along  several  mesenchymal 
tissue  lineages,  including  adipocytes,  osteoblasts, 
myocytes, chondrocytes, endothelial cells, and car-
diomyocytes (Zuk et al., 2001; Gimble et al., 2007). 
Such cells can also be induced into neuro-like cells 
or a Schwann cell phenotype in vitro (Safford et al., 
2002; Ning et al., 2006; Kingham et al., 2007), and 
intra-cerebral transplantation of human ADSCs can 
improve neurological deficits after cerebral ischemia 
in rats (Kang et al., 2003). In addition, liposuction 
is  a  common  and  safe  surgical  procedure,  while 
subcutaneous  adipose  tissue  is  abundant,  read-
ily accessible, and relatively expendable, so enough 
ADSCs can be obtained with minimal risk (Fraser 
et al., 2006). Adipose-derived stem cells seem more 
suitable than BMSCs for nerve tissue engineering as 
alternative cell sources of Schwann cells (SCs). 
In all methods of inducing BMSC neural dif-
ferentiation in vitro, co-culture seems a simple and 
effective  approach.  After  performing  direct  co-
culture  of  SCs  and  BMSCs,  Zurita  suggested  that 
intercellular contacts could play an important role in 
the process of BMSC neural differentiation (Zurita 
et al., 2005). However, according to previous studies 
(Ying et al., 2002; Alvarez et al., 2003; Wang et al., 
2003; Chen et al., 2006), the possibility of cell fusion 
cannot be excluded, so Zurita performed indirect 
co-culture of SCs and BMSCs in transwell culture 
dishes  and  proved  BMSCs  neural  differentiation 
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even if without intercellular contacts (Zurita et al., 
2007). This means that only by means of cell factors 
secreted by SCs, BMSCs can also differentiate into 
neuro-like  cells  successfully.  But  until  now,  there 
were no reports about whether ADSCs could real-
ize  neural  differentiation  only  by  co-culture  with 
SCs. To solve this problem, we applied transparent 
polycarbonate  membranes  with  pores  of  1.0  µm 
to  impede  contact  between  SCs  and  ADSCs  and 
performed an indirect co-culture, hoping to induce 
ADSC  neural  differentiation  and  investigate  the 
regularity of such differentiation at different time 
points (1, 3, 7, 14 d) after co-culture.
MATERIAL AND METHODS
All  animal  experiments  described  in  this  report 
were approved by the Ethical Guideline Committee 
for Animal Care of West China College of Medical 
Sciences, Sichuan University.
Isolation, culture, and identification of ADSCs and SCs
Adipose-derived stem cells were isolated from sub-
cutaneous adipose tissue of the inguinal region of 
adult  Sprague-Dawley  rats.  The  subcutaneous  fat 
was carefully dissected and then enzymatically dis-
sociated for 60 min at 37°C using 0.1% (w/v) col-
lagenase type I (Sigma, UK) and passed through a 
75-μm filter to remove undissociated tissues, after 
which it was neutralized by the addition of alpha-
Modified Eagle Medium (α-MEM; Hyclone, USA) 
containing  20%  (v/v)  fetal  bovine  serum  (FBS, 
Hyclone, USA) and centrifuged at 1000×g for 8 min. 
The stromal cell pellet was resuspended in α-MEM 
containing 20% (v/v) FBS (Hyclone, USA) with 1% 
(v/v) penicillin/streptomycin solution. Cultures were 
maintained at subconfluent levels in an incubator at 
37°C with 5% CO2 and passaged with trypsin/EDTA 
(Sigma, UK) when required.
Schwann cells were isolated from the bilateral 
sciatic  nerves  of  1-  to  2-day-old  Sprague-Dawley 
rat pups according to previous reports (Zurita et al., 
2005) and cultured in α-MEM containing 20% (v/v) 
FBS (Hyclone, USA) with 2 μM forskolin (Sigma, 
UK), 20 ng/ml basic fibroblast growth factor (bFGF; 
PeproTech Ltd., UK), and 1% (v/v) penicillin/strep-
tomycin solution. The culture medium was changed 
every 72 h.
Adipose-derived  stem  cells  at  passage  3  were 
identified by immunocytochemistry with antibod-
ies against Stro-1, CD90, CD10, CD146, CD44, and 
CD34 (1:100, Santa Cruz, CA, USA). The multiple 
differentiation  potential  of  these  ADSCs  was  also 
investigated  as  previously  described  (Kingham  et 
al., 2007). For osteogenic induction, cultures were 
treated with 100 μg/ml ascorbate, 0.1 μM dexameth-
asone, and 10 mM β-glycerophosphate for 3 weeks. 
Cells were then fixed with 4% (w/v) paraformalde-
hyde for 30 min at room temperature, washed three 
times  with  phosphate-buffered  saline  (PBS),  and 
then incubated with 1% (w/v) Alizarin Red solu-
tion to stain for calcium deposition. For adipogenic 
induction, cells were treated with 0.5 mM isobutyl-
methylxanthine (IBMX), 1 µM dexamethasone, 10 
µM insulin, and 200 µM indomethacin for 3 weeks. 
Cells were then fixed with 10% (v/v) formalin for 60 
min, washed in H2O, and stained for lipid clusters 
with Oil Red O. Stem cells were identified in living 
cultures on the basis of cell soma and nuclear mor-
phology. They were also identified by immunocy-
tochemical labeling for S100 protein with antibody 
against  S100  (1:100,  Santa  Cruz,  CA,  USA).  The 
cover slips were examined using an Olympus IX 70 
inverted fluorescence microscope.
Co-culture of ADSCs and SCs
To co-culture ADSCs and SCs, we used transwell 
culture  dishes  with  a  polycarbonate  membrane 
(Millipore, USA). The pore size of membranes in 
our experiment was 1.0 µm, which is much smaller 
than size of the ADSC body (approximately 80-160 
µm)  and  therefore  greatly  inhibits  the  migration 
of ADSCs into the lower chamber. Schwann cells 
(6×104 cells/cm2, in 3 ml of culture medium) were 
cultured in the well, and ADSCs (3×104 cells/cm2) 
were cultured on the permeable membrane support, 
with  co-cultures  maintained  in  α-MEM  contain-
ing 20% (v/v) FBS, so that both types of cells were 
exposed to the same culture media conditions, with-
out cell contacts (Zurita et al., 2007). Meanwhile, 
ADSCs cultured on the permeable membrane sup-
port without SCs in the lower chamber were taken as ADSCS NEURAL DIFFERENTIATION 705
control groups. At different time points (1, 3, 7, 14 d) 
after co-culture, all the membranes were cut down 
from the insert and mounted on glass cover slips for 
immunostaining. 
Immunoassaying and Western blotting
For immunoassaying, cells were cultured on glass 
cover slips for 24 h and fixed in 4% (w/v) parafor-
maldehyde in phosphate-buffered saline (PBS, pH 
7.5) for 30 min, washed with PBS thoroughly and 
treated  with  3%  (v/v)  H2O2  for  5  min,  incubated 
for 1 h with blocking buffer [5% (w/v) normal goat 
serum (Sigma, UK)/0.1% (w/v) TritonX-100 in PBS, 
pH 7.5], then incubated with primary antibodies, 
including  mouse  antibodies  against  S100  (1:100, 
Santa  Cruz,  USA),  glial  fibrillary  acidic  protein 
(GFAP)  (1:200,  Santa  Cruz),  Nestin  (1:100,  Santa 
Cruz),  Stro-1  (1:100,  Santa  Cruz),  CD90  (1:100, 
Santa  Cruz),  CD10  (1:100,  Santa  Cruz),  CD146 
(1:100, Santa Cruz), CD44 (1:100, Santa Cruz), and 
CD34 (1:100, Santa Cruz) at 4°C overnight. After 
thorough washing, the cover slips were incubated 
with secondary biotinylated antibodies and horse-
radish peroxide-conjugated streptavidin. The perox-
idase reaction was developed using 3, 30-diamino-
benzidine tetrahydrochloride (DAB) as chromogen. 
The cells were counterstained with hematoxylin and 
then examined using an Olympus IX 70 inverted 
phase contrast microscope (Olympus, JAPAN). Stro-
1 and anti-mouse fluorescein isothiocyanate (FITC)-
conjugated secondary antibody (1:100, Santa Cruz) 
were used to label ADSCs, after which fluorescence 
signals  were  detected  at  emission  wavelength  of 
488/522 nm (FITC, green) with an Olympus IX 70 
inverted  phase  contrast  fluorescence  microscope 
(Olympus, JAPAN).
Protein from co-cultured ADSCs and ADSCs of 
control groups was extracted with a commercially 
available  protein  assay  kit  (Bio-Rad,  UK).  After 
determination of protein concentrations, 20 μg of 
the  protein  was  mixed  with  an  equal  amount  of 
2  ×  sodium  dodecyl  sulfate  (SDS)  loading  buffer 
for  Western  blot  analysis  as  previously  reported 
(Kingham et al., 2007). Proteins were denatured at 
99°C for 5 min, then resolved at 120 V on 15% (for 
S100) or 10% (for GFAP and Nestin) sodium dodec-
yl  sulfate  polyacrylamide  gels.  Following  electro-
phoretic transfer to polyvinylidene difluoride mem-
branes, membranes were blocked for 1 h in 5% (w/v) 
non-fat dry milk in TBS-Tween (10 mM Tris pH 7.5, 
100 mM NaCl, 0.1% (v/v) Tween). The membranes 
were then incubated overnight at 4°C with primary 
antibodies,  including  mouse  antibodies  to  S100 
(1:200, Santa cruz, CA, USA), mouse antibodies to 
nestin (1:200, Santa Cruz, USA), mouse antibodies 
to  GFAP  (1:200,  Santa  Cruz,  USA),  and  GAPDH 
(1:500, Santa Cruz, USA). After washing with TBS-
Tween, membranes were incubated with horserad-
ish peroxidase-conjugated secondary antibody (goat 
anti-mouse, 1:1000; Santa Cruz, USA) at room tem-
perature for 1 h. The loading control was GAPDH 
antibody.  The  blots  were  developed  via  enhanced 
chemiluminescence (Pierce, Rockford, IL, USA) and 
were digitally scanned (Bio-Rad, CA, USA). 
RNA reverse transcriptase polymerase chain reaction 
(RT-PCR) and quantitative real-time PCR
(qRT-PCR) analysis
Total RNA was extracted from all of the specimens 
at different time points (1, 3, 7, 14 d) using the Trizol 
Reagent (Invitrogen, USA) according to the manu-
facturer’s instructions. The yield and quality of the 
RNA were assessed by measuring the absorbance at 
260 and 280 nm, followed by electrophoresis on 3% 
(w/v) agarose gels. Total RNA (500 ng) was reverse-
transcribed into complementary DNA (cDNA) with 
the  PrimeScriptTM  RT  Reagent  Kit  (Perfect  Real 
Time, Takara, Japan) according to the manufactur-
er’s guidelines. Primers of S100, GFAP, Nestin, and 
the internal calibrator [glyceraldehyde-3-phosphate 
dehydrogenase  (GAPDH)  (synthesized  by  Takara 
Biological  Technology  Co.  Ltd,  Dalian,  China)] 
are  listed  in  Table  1.  A  25-μl  PCR  reaction  solu-
tion (2×SYBR Premix Ex TaqTM 12.5 μl; 10 μmol/l 
forward primer 0.5 μl; 10 μmol/l reverse primer 0.5 
μl; 50×ROX Reference Dye1 0.5 μl, cDNA 2 μl; and 
dH2O 9 μl) was amplified in the Applied Biosystems 
7300 Real-Time PCR System (ABI, USA). The ther-
mocycle of the PCR reaction was as follows: after 
an initial denaturation at 95°C for 10 s, 45 cycles of 
denaturation at 95°C for 5 s and annealing at 60°C 
for 31 s were performed. The PCR products went 
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RAD, USA). During the real-time PCR process, the 
fluorescence signal was collected during annealing 
steps. The value of Ct (cycle of threshold) was calcu-
lated for further statistical analysis. In order to exam-
ine the efficiency of real-time PCR, standard curves 
were established with serial dilution of sample RNA 
(500 ng; S100, GFAP, Nestin, GAPDH, 10 × dilu-
tion). Total RNA of ADSCs in control groups was 
taken as a non-template control, which was included 
in all experiments and performed with RT-PCR to 
evaluate DNA contamination of reagents used for 
amplification. None of the experiments resulted in a 
positive signal from the non-template controls.
Statistical analyses
All data were expressed as the mean ± SEM. Statistical 
calculations  were  performed  using  the  SPSS  soft-
ware  (SPSS,  Chicago,  IL,  USA).  Inter-group  com-
parisons were made by one-way analysis of variance 
(ANOVA), after which Tukey’s honestly significant 
difference test (Tukey HSD) was adopted to perform 
multiple inter-group comparisons. Values of P less 
than 0.05 were considered to be significant.
RESULTS
Immunocytochemical assessment of ADSC stem cell 
markers showed positive for Stro-1, CD90, CD10, 
CD146,  and  CD44,  but  totally  negative  for  CD34 
(Fig. 1). As there were no specific markers, ADSCs 
were identified on the basis of a complex immune 
phenotype characterized by the lack of a hematopoi-
etic stem cell marker such as CD34 and expression 
of a number of surface molecules, including CD90, 
CD10,  CD146,  CD44,  and  STRO-1  (Ning  et  al., 
2006; Krampera et al., 2007). To investigate the mul-
Table 1. Primer sets for RT-PCR and quantitative real-time PCR analysis. For. and Rev. indicate forward and reverse primers, respec-
tively. All primers were purchased from Takara Biological Technology Co. Ltd, (Dalian, China).
Gene Primer sequences (5’-3’) Product size (bp) Annealing tempera-
ture (°C) °C) )
GenBank accession 
No.
S-100 For.: ctgccaaaacaggatctcagc
Rev.: cttgttcagggtgtcaggatgt 101 62.4 L18948
NESTIN For.: agaagctgggtctgaagcacta
Rev.: gggagtagagtcagggagagttt 148 58.3 NM012987
GFAP For.: gagggacaatctcacacaggac
Rev.: gactcaaccttcctctccagat 156 62.4 NM017009
GAPDH For.: tatgactctacccacggcaagt
Rev.: atactcagcaccagcatcacc 138 61.8 NW047717
Fig. 1. Identification of ADSCs. Immunocytochemical assess-
ments of ADSC stem cell markers: a. CD90 (+), b. CD10 (+), 
c. CD44 (+), d. CD146 (+), e. CD34 (-), f. Stro-1(+), g. Aliza-
rin red staining showed some mineralized nodule formation in 
ADSCs cultures, h. cultured ADSCs formed Oil Red O-positive 
lipid clusters. Scale bar = 100 µm (a, b, c, d, e, g, h); scale bar 
= 50 µm (f).
Fig. 2. Identification  of  SCs.a.  Immunocytochemical  assess-
ment of Schwann cells showing positive for S100 protein, b. 
morphology of Schwann cells under phase contrast microscope 
showing typical elongated spindle shape. Scale bar = 100 µm.ADSCS NEURAL DIFFERENTIATION 707
tiple differentiation potential of cells isolated from 
subcutaneous adipose tissue, they were treated with 
agents known to induce differentiation into osteo-
blastic  and  adipogenetic  phenotypes.  Osteogenic 
differentiation was confirmed by the production of 
calcium deposits detected with Alizarin Red (Fig. 1) 
and adipogenic differentiation by the presence of Oil 
Red O-positive lipid clusters (Fig. 1). With respect to 
morphology, SCs under a phase contrast microscope 
had a typical elongated spindle shape, and immuno-
cytochemical assessment showed positive for S100 
protein with high purity (Fig. 2).
The morphology of co-cultured ADSCs began to 
change as early as 24 h after co-culture, showing the 
elongated spindle shape characteristic of SCs, and 
co-cultured ADSCs with that shape became more 
and more numerous with the passage of time. Nestin 
protein is a neural progenitor cell marker, while both 
S-100 and GFAP protein are glial markers; they are 
all cell markers for identifying SCs (Ning et al., 2006; 
Kingham  et  al.,  2007).  Our  immunocytochemical 
assessment of co-cultured ADSCs showed positive 
Fig. 3. Morphological and immunocytochemical assessments of co-cultured ADSCs. With respect to morphology, co-cultured AD-
SCs showed the elongated spindle shape characteristic of Schwann cells as early as 24 h after co-culture (a), while at 3, 7, and 14 days 
after co-culture, co-cultured ADSCs with that shape became more and more numerous (e, i, m). Immunocytochemical assessments 
of co-cultured ADSCs at different time points (1, 3, 7, 14 d) showed positive for S-100 (b, f, j, n), Nestin (c, g, k, o), and GFAP (d, h, 
l, p), but the percentage of positive cells could not be counted precisely because the transparency of the polycarbonate membranes 
was not good enough, so we could not perform precise quantitative analyses only on the basis of immunocytochemical pictures. 
Scale bar = 100 µm.XIAOJIE LI ET AL. 708
for  S-100,  Nestin,  and  GFAP  protein  at  all  time 
points (1, 3, 7, 14 d), but the percentage of positive 
cells  could  not  be  counted  precisely  because  the 
transparency of the polycarbonate membranes was 
not good enough, so we could not perform a precise 
quantitative analysis using only immunocytochemi-
cal pictures (Fig. 3). On the other hand, cultured 
ADSCs  in  the  control  groups  kept  their  original 
small round or polygonal shape without changing to 
an elongated spindle shape, and these undifferenti-
ated ADSCs showed negative for S-100, Nestin, and 
GFAP protein all the time. To confirm the results 
obtained  by  immunocytochemistry,  Western  blot-
ting was performed (Fig. 4). Lyzates of co-cultured 
ADSCs at 1, 3, 7, and 14 days – but not ADSCs from 
the control groups – showed a GFAP-immunoreac-
Fig. 4. Western blot analysis of Schwann cell-related proteins. 
Lyzates of co-cultured ADSCs at 1, 3, 7, and 14 days and lyzates 
of ADSCs from control groups were blotted for S100, Nestin, 
and GFAP proteins (GAPDH was used as a loading control).
Fig. 5. RT-PCR gel electrophoresis images. In above figures, all 
the co-cultured ADSCs at 1, 3, 7, and 14 days show positive 
strips for gene S100, Nestin, and GFAP in different degrees, 
while the ADSCs from control groups show no positive strips 
for S100, Nestin, and GFAP. We use GAPDH as a reference for 
assessing the PCR efficiency.
Table 2. Relative differences in S100 gene expression. *Means 
for groups in homogeneous subsets are displayed. **Uses har-
monic mean sample size = 3.000. Tukey HSD) Tukey’s honestly 
significant difference test; Sig) significance.
Time point (d) N
Subset for alpha = .05
1* 2*
Tukey HSD**
1 3 .0000
3 3 .3010
7 3 3.3580
14 3 4.5787
Sig. .750 .217
Table 3. Relative differences in Nestin gene expression. *Means 
for groups in homogeneous subsets are displayed. **Uses har-
monic mean sample size = 3.000. Tukey HSD) Tukey’s honestly 
significant difference test; Sig) significance.
Time point (d) N
Subset for alpha = .05
1* 2*
Tukey HSD**
3 3 .0000
1 3 .2188
7 3 4.5641
14 3 4.7800
Sig. .995 .995
Table 4. Relative differences in GFAP gene expression. *Means 
for groups in homogeneous subsets are displayed. **Uses har-
monic mean sample size = 3.000. Tukey HSD) Tukey’s honestly 
significant difference test; Sig) significance.
Time point (d) N
Subset for alpha = .05
1*
Tukey HSD**
1 3 .0000
3 3 .7246
7 3 1.2984
14 3 1.4477
Sig. .058ADSCS NEURAL DIFFERENTIATION 709
Fig. 6. Relative differences in S100, Nestin, and GFAP gene ex-
pression of co-cultured ADSCs. In the graph, bar height repre-
sents the relative quantity of gene expression (mean + SEM). 
For the relative quantities of S100 and Nestin gene expression, 
analyses showed no statistical differences between 1 and 3 d 
and between 7 and 14 d (P > 0.05), but the results for 7 or 14 
d had significant statistical differences compared to those for 
1 or 3 d (P < 0.05); for the relative quantities of GFAP gene 
expression, there were no statistical differences at 1, 3, 7, and 
14 d (P > 0.05).
tive band corresponding to a molecular weight of 50 
kDa. Nestin and S100 proteins were also detected in 
co-cultured ADSCs, but were absent in ADSCs from 
the control groups.
We also performed RT-PCR, and the results were 
consistent  with  immunocytochemistry  and  western 
blotting (Fig. 5). Subsequently, quantitative real-time 
PCR was performed to investigate the relative quanti-
tative differences in gene expression of the above three 
genes at different time points (1, 3, 7, 14 d). For S100 
and Nestin, analyses showed no statistical differences 
between 1 and 3 d and between 7 and 14 d (P > 0.05), 
but results for 7 and 14 d had significant statistical dif-
ferences compared to those for 1 and 3 d (P < 0.05), 
which meant that the relative quantities of S100 and 
Nestin gene expression were higher at 7 and 14 d than 
at 1 and 3 d (Tables 2 and 3). For GFAP, there were 
no statistical differences at 1, 3, 7, and 14 d (P > 0.05), 
which meant that the relative quantity of GFAP gene 
expression maintained a stable level from 1 to 14 days 
without apparent fluctuation (Table 4). To make the 
results clear and direct, we used a bar graph to show 
relative quantitative differences at different time points 
(1, 3, 7, 14 d) for S100, Nestin, and GFAP (Fig. 6).
DISCUSSION
Our studies showed that ADSCs can differentiate into 
a Schwann cell phenotype only as a result of being 
co-cultured with SCs indirectly, excluding the pos-
sibility of cell fusion. Previous studies reported that 
BMSCs can be induced to undergo neural differen-
tiation in the presence of certain cell growth factors 
such as BDNF, NGF, bFGF, PDGF, etc. (Sanchez et (Sanchez et 
al., 2000; Tohill et al., 2004; Tao et al., 2005; Caddick 
et al., 2006). Recently,twopapersreportedthatwhen Recently, two papers reported that when 
supplemented with certain cell growth factor com-
pounds, ADSCs can also be induced to differentiate 
into a Schwann cell phenotype (Kingham et al., 2007; 
Krampera et al., 2007). Adult SCs can secrete BDNF 
and NGF (Yamamoto et al., 1993), which makes it 
possible for stem cells to differentiate into neuro-
like cells when co-cultured with SCs. Zurita et al. 
performed  indirect  co-culture  of  SCs  and  BMSCs 
in transwell culture dishes and demonstrated neural 
differentiation of BMSCs (Zurita et al., 2007). We 
observed  that  ADSCs  began  morphologic  change 
as early as 1 day after co-culture, expressing S100, 
Nestin, and GFAP to judge from immunocytochem-
ical staining and RT-PCR analysis, and such expres-
sions  lasted  until  two  weeks  later.  These  results 
showed  that  neurotrophic  SC  factors  can  induce 
rapid  and  stable  neural  differentiation  of  ADSCs, 
which is in keeping with previous research (Tao et 
al., 2005; Kingham et al., 2007; Zurita et al., 2007). 
On the basis of the above analyses, we believe that 
co-culture represents a simple and effective way of 
inducing neural differentiation of ADSCs.
In our studies, S100 protein, a special cell marker 
of Schwann cells, showed a relative quantity of gene 
expression that climbed from the 1st to 7th day, then 
remained stable until the 14th day. Nestin, a neural 
progenitor marker, exhibited the same regularity as 
S100 gene expression. As for GFAP, a glial marker, 
although we could see directly from the bar graph 
(Fig. 6) that the relative quantities of its gene expres-
sion increased continually from the 1st to 14th day, XIAOJIE LI ET AL. 710
there were no statistical differences between 1, 3, 7, 
and14 d. The S100 protein, Nestin, and GFAP are all 
recognized as cell surface markers of SCs (Zurita et 
al., 2005, 2007; Caddick et al., 2006; Kingham et al., 
2007). Their strong gene expression in our co-cul-
tured ADSCs indicated neural differentiation toward 
a  Schwann  cell  phenotype.  Analyzing  the  above 
results,  we  conclude  that  although  ADSCs  began 
neural differentiation as early as 1 day after co-cul-
ture, significant neural differentiation appeared at 
least 7 days later, and such differentiations can last 
at least two weeks. In other words, we needed at least 
7 days to co-culture ADSCS with SCs in vitro before 
the co-cultured ADSCs could be transplanted into 
areas with peripheral nerve defects in vivo for nerve 
repair. Zurita et al. suggested previously that in vitro 
neural  differentiation  of  BMSCs  is  unnecessary 
when BMSCs are used in grafting procedures for 
nervous system repair (Zurita et al., 2007). However, 
further investigation is needed to establish whether 
prior in vitro neural differentiation of ADSCs would 
be more effective for nerve repair in vivo.
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